Knowledge gaps and research priorities in tuberculous meningitis

Tuberculous Meningitis International Research Consortium

Research output: Contribution to journalLetterpeer-review

Abstract

Tuberculous meningitis (TBM) is the most severe and disabling form of tuberculosis (TB), accounting for around 1-5% of the global TB caseload, with mortality of approximately 20% in children and up to 60% in persons co-infected with human immunodeficiency virus even in those treated. Relatively few centres of excellence in TBM research exist and the field would therefore benefit from greater co-ordination, advocacy, collaboration and early data sharing. To this end, in 2009, 2015 and 2019 we convened the TBM International Research Consortium, bringing together approximately 50 researchers from five continents. The most recent meeting took place on 1st and 2nd March 2019 in Lucknow, India. During the meeting, researchers and clinicians presented updates in their areas of expertise, and additionally presented on the knowledge gaps and research priorities in that field. Discussion during the meeting was followed by the development, by a core writing group, of a synthesis of knowledge gaps and research priorities within seven domains, namely epidemiology, pathogenesis, diagnosis, antimicrobial therapy, host-directed therapy, critical care and implementation science. These were circulated to the whole consortium for written input and feedback. Further cycles of discussion between the writing group took place to arrive at a consensus series of priorities. This article summarises the consensus reached by the consortium concerning the unmet needs and priorities for future research for this neglected and often fatal disease.

Original languageEnglish (US)
Article number188
JournalWellcome Open Research
Volume4
DOIs
StatePublished - 2019

Bibliographical note

Funding Information:
Grant information: This work was supported by the Wellcome Trust through a Senior Research Fellowship to RJW [104803]; an Investigator

Funding Information:
Award to GET [110179]; a core grant to the Centre for Infectious Diseases Research in Africa (CIDRI-Africa) [203135], awarded to RJW; and funding for the Francis Crick Institute [FC001218]. JAS is supported by a Clinician Scientist Fellowship jointly funded by the UK Medical Research Council (MRC) and the UK Department for International Development (DFID) under the MRC/DFID Concordat agreement [MR/R007942/1]. RJW is also supported by Meningitis Now; European & Developing Countries Clinical Trials Partnership 2 [RIA2017T-2019]; and Francis Crick Institute, which receives funding from Cancer Research UK [FC0010218], UK Research and Innovation [FC0010218], and the Wellcome Trust [FC0010218]. AF is supported through the National Research Foundation South African Research Chairs Initiative (NRF SARChI) as a Chair of Clinical Neurosciences.

Keywords

  • Care cascade
  • Critical care
  • Diagnosis
  • Epidemiology
  • Research priorities
  • Treatment
  • Tuberculosis
  • Tuberculous meningitis

Fingerprint Dive into the research topics of 'Knowledge gaps and research priorities in tuberculous meningitis'. Together they form a unique fingerprint.

Cite this